Michael Martin

Chief Business Officer

Michael Martin is Aurinia’s Chief Business Officer. In addition to being a co-founder, Mike has held a variety of roles within the company, including Chief Operating Officer, and has played an integral role in business development efforts, partner management, licensing and patent portfolio management.

Mike was previously CEO and Director of Aurinia Pharmaceuticals Inc., prior to its acquisition by Isotechnika in 2013, helping bring the company into a structure capable of advancing voclosporin towards approval. Mike spearheaded a complex transaction to form the modern-day Aurinia.

Before joining Aurinia, Mike was Director, Global Business Development & Licensing at Vifor Pharma and was a key member at Aspreva, where he initiated the global strategic launch planning process for CellCept® in lupus nephritis. Before that, Mike held a variety of progressively senior sales and commercial positions at Schering-Plough.

Mike earned a B.S. in biochemistry from the University of Victoria.